Identification of ryanodine receptor isoforms in prostate DU-145, LNCaP, and PWR-1E cells

Biochemical and Biophysical Research Communications

Volumn 425, Issue 2, 2012, Pages 431-435

  Kobylewski, Sarah E ^a   Henderson, Kimberly A ^a   Eckhert, Curtis D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Boric acid; Cancer models; DU 145; Isoform; LNCaP; Prostate cancer; PWR 1E; Ryanodine receptor

Indexed keywords

CALCIUM ION; ISOPROTEIN; RYANODINE RECEPTOR 1; RYANODINE RECEPTOR 2; RYANODINE RECEPTOR 3;

ARTICLE; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL STRAIN LNCAP; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

CALCIUM; CELL LINE, TUMOR; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 84865387871     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.07.119     Document Type: Article

References (29)

1. Balk S.D., Whitfield J.F., Youdale T., Braun A.C. Roles of calcium, serum, plasma and folic acid in the control of proliferation of normal and Rous sarcoma virus-infected chicken fibroblasts. Proceedings from the National Academy of Sciences USA 1973, 70.
2. Abeele F.V., Shuba M., Roudbaraki L., Lemonnier L., Vanoverberghe K., Mariot P., Skryma R., Prevarskaya N. Store-operated Ca2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis. Cell Calcium 2003, 33:357-373.
3. J.F. Whitfield, Calcium in cell cycles and cancer, second edition, Boca Raton, CRC Press, 1995.
4. Abdul M., Ramlal S., Hoosein N. Ryanodine receptor expression correlates with tumor grade in breast cancer. Pathological Oncology Research 2008, 14:157-160.
5. Fill M., Copello J.A. Ryanodine receptor calcium release channels. Physiological Review 2002, 82:893-922.
6. Lee B.S., Sessanna S., Laychock S.G., Rubin R.P. Expression and cellular localization of a modified type 1 ryanodine receptor and L-type channel proteins in non-muscle cells. Journal of Membrane Biology 2002, 189:181-190.
7. Hamilton S.L., Serysheva I.I. Ryanodine receptor structure: progress and challenges. Journal of Biological Chemistry 2009, 284:4047-4051.
8. Kimlicka L., Petegem F.V. The structural biology of ryanodine receptors. Science China Life Sciences 2011, 54:712-724.
9. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
10. Zalk R., Lehnart S.E., Marks A.R. Modulation of the ryanodine receptor and intracellular calcium. Annual Review of Biochemistry 2007, 76:367-385.
11. Bennett D.L., Cheek T.R., Berridge M.J., Smidt H.D., Parys J.B., Missiaen L., Bootman M.D. Expression and function of ryanodine receptors in nonexcitable cells. Journal of Biological Chemistry 1996, 271:6356-6362.
12. Mori F., Fukaya M., Abe H., Wakabayashi K., Watanabe M. Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. Neuroscience Letters 2000, 285:57-60.
13. Mackrill J.J. Ryanodine receptor calcium channels and their partners as drug targets. Biochemical Pharmacology 2010, 79.
14. Matsuo N., Tanada K., Nakanishi K., Yamasaki N., Toyama K., Takao K., Takeshima H., Miyakawa T. Comprehensive behavioral phenotyping of ryanodine receptor type 3 (RyR3) knockout mice: decreased social contact duration in two social interaction tests. Frontiers in Behavioral Neuroscience 2009, 3:1-13.
15. Pessah I.N., Cherednichenko G., Lein P.J. Minding the calcium store: ryanodine receptor activation as a convergent mechanism of PCB toxicity. Pharmacology and Therapeutics 2010, 125:260-285.
16. Bergner A., Huber R.M. Regulation of the endoplasmic reticulum Ca2+ store in cancer. Anti-Cancer Agents in Medicinal Chemistry 2008, 8.
17. Kaufmann R., Hollenberg M.D. Proteinase-activated receptors (PARs) and calcium signaling in cancer. Advances in Experimental Medicine and Biology 2012, 740.
18. Westcott E.B., Jackson W.F. Heterogeneous function of ryanodine receptors, but not IP3 receptors, in hamster cremaster muscle feed arteries and arterioles. American Journal of Heart and Circulation Physiology 2011, 300.
19. Barranco W.T., Eckhert C.D. Boric acid inhibits human prostate cancer cell proliferation. Cancer Letters 2004, 216:21-29.
20. Sobel R.E., Sadar M.D. Cell lines used in prostate cancer research: a compendium of old and new lines-part 2. The Journal of Urology 2005, 173:360-372.
21. Jacob K., Webber M., Benayahu D., Kleinman H.K. Osteonectin promotes prostate cancer cell migration and invasion: a possible mechanism for metastasis to bone. Cancer Research 1999, 59:4453-4457.
22. Henderson K., Stella S.L., Kobylewski S., Eckhert C.D. Receptor activated Ca(2+) release is inhibited by boric acid in prostate cancer cells. PLoS One 2009, 4:e6009.
23. Giannini G., Conti A., Mammarella S., Crobogna M., Sorrention V. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. Journal of Cell Biology 1995, 128:893-904.
24. Saldana C., Diaz-Munoz M., Antaramian A., Gonzalez-Gallardo A., Garcia-Solis P., Morales-Tlalpan V. MCF-7 breast carcinoma cells express ryanodine receptor type 1: functional characterization and subcellular localization. Molecular Cell Biochemistry 2009, 323:39-47.
25. Mariot P., Prevarskaya N., Roudbaraki M., Bourhis X.L., Coppenolle F.V., Vanoverberghe K., Skryma R. Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells. The Prostate 2000, 43:205-214.
26. Deli T., Varga N., Adam A., Kennessey I., Raso E., Puskas L.G., Tovari J., Fodor J., Feher M., Sziegeti G.P., Csernoch L., Timar J. Functional genomics of calcium channels in human melanoma cells. International Journal of Cancer 2007, 121:55-65.
27. Barranco W.T., Kim D.H., Stella S.L., Eckhert C.D. Boric acid inhibits stored Ca2+ release in DU-145 prostate cancer cells. Cell Biology and Toxicology 2009, 25:309-320.
28. Barranco W.T., Eckhert C.D. Cellular changes in boric acid-treated DU-145 prostate cancer cells. British Medical Journal 2006, 94.
29. Wehrens X.H.T., Lehnart S.E., Marks A.R. Intracellular calcium release and cardiac disease. Annual Review of Physiology 2005, 67:69-98.